Skip to content

Daktronics DAKT Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

MGN
MagniteMGNI
Scholastic logo
ScholasticSCHL
Vontier logo
VontierVNT
Resideo Technologies, Inc. logo
Resideo Technologies, Inc.REZI
Wabtec logo
WabtecWAB

Other financials

Income statement

See full
Revenue$208.6M+20.9%
Gross profit$58.5M+35.5%
Operating income$14.1M
Net income$8.4M+189%
EPS (diluted)$0.17+185%

Balance sheet

See full
Cash & equivalents$131.6M+3.2%
Total debt$8.5M-49.4%
Total equity$300.7M+10.6%
Total assets$554.4M+10.2%

Cash flow

See full
Operating cash flow$11.7M-2.5%
CapEx$4.5M-6.3%
Free cash flow$8.1M+3.4%

Valuation

See full
Market cap$934.57M+31.6%
Enterprise value$811.43M+35.4%
P/E20.6×
P/S1.1×+0.2×

Profitability

See full
Gross margin27.3%+1.5pp
Operating margin7.3%+2.6pp
Net margin5.4%+4.5pp
FCF margin7.7%-0.6pp

Returns & leverage

See full
Return on equity15.8%+13.2pp
Debt / equity0.0×
Current ratio2.3×+0.1×

Where this comes from

Reported directly by Daktronics in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Daktronics’s 10-Q, filed March 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Daktronics's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Daktronics's common stock, shares authorized (in shares)?
Daktronics (DAKT) reported common stock, shares authorized (in shares) of $115M in Q4 2025.
How has Daktronics's common stock, shares authorized (in shares) changed year-over-year?
Daktronics's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $115M to $115M.
What is the long-term trend for Daktronics's common stock, shares authorized (in shares)?
Over 3 years (2022 to 2025), Daktronics's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $115M to $115M.